INmune Bio's initial results from cohort 1 of the phase I/II CaRe PC trial, using INKmune for the treatment of patients with ...

People aged 85 and older had the highest rate of suicide death in 2022, according to the Centers for Disease Control and ...

A national event by Pet Partners was held Saturday by its Chico affiliate chapter, in order to educate locals about their pet ...

Larry, Moe and Curly are settling in at ServiceNet’s group home and are embracing their role not as a comedic trio, but as ...

Teacher Alexius Harvey (far left) manages a classroom of active children at the preschool of Easterseals Arkansas, which ...

Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...

The leaves are falling, the outdoor temperatures are getting cooler, and the nature educational programs are in full swing at Baltimore Woods Nature Center. In addition to enjoying the four new trails ...

An in-home, voice-activated cognitive behavioral therapy (CBT) program improves insomnia symptoms among breast cancer ...

Pfizer’s sudden market withdrawal of sickle cell therapy Oxbryta, which some analysts predicted would reach $750 million in ...

For 12 years, Paul Stroud's done everything he can to combat the effects of Parkinson's disease. He had a pair of stimulators implanted deep in his brain. He takes the standard medications to treat ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing ...